Premium apparel maker Ralph Lauren Co. NYSE: RL reported its fiscal Q4 2024 earnings report with lowered guidance, causing a predictability gap in shares the following morning. However, the initial drop to $159.10 reversed as the market reassessed the results, turning sentiment bullish and causing shares to surge back up to $173.45 in the following days. Investors are wondering what caused the sentiment reversal and if the gains will stick.

Ralph Lauren competes in the consumer discretionary sector with premium brand apparel makers like Guess? Inc. NYSE: GES and PVH Co. NYSE: PVH, maker of Tommy Hilfiger and Calvin Klein.

Premium All-American Fashion: Ralph Lauren’s Legacy

As a brand, Ralph Lauren embodies the spirit of the American Dream premium lifestyle through its line of Polo, RLX, RL, Lauren, Chaps, Polo Sport, Black Label, and the most expensive Purple Label fragrances, clothing, and accessories for men, women, and children. Some of its Polo products can be found on rare occasions at discount retailers like Ross Stores Inc. NASDAQ: ROST.

They’ve expanded their products to include home goods, accessories, and expensive high-end furniture. Their Ralph Lauren Writer’s Chair sells for $14,180, or you might consider plunking down $36,470 for a Ralph Lauren Clivedon Tufted Bed. Their brand company even considers opening a premium hotel after inspiring many boutique hotels to adopt its designer logos.

Daily Cup Pattern and Strong Q4 Performance for Ralph Lauren

Ralph Lauren completed a daily cup pattern, beginning at the cup lip line of $177.45 on April 2, 2024. Ralph Lauren’s stock fell to a low of $156.91 on April 19, 2024. Shares rallied back to $167.31 and were chopped sideways until its fiscal Q4 2024 earnings release, which caused a gap down and squeezed back up. Ralph Lauren completed the cup pattern upon surging through $177.85 and entering the gap-fill zone. The $183.75 would complete the gap filled on the April 2, 2024, gap down. The daily relative strength index (RSI) is rising to the 70-band. Pullback support levels are at $174.82, $170.92, $167.31, and $161.81.

In fiscal Q4 2024, Ralph Lauren reported an earnings per share (EPS) of $1.71, beating analyst estimates by 4 cents. Revenues rose 1.8% YoY to $1.57 billion, matching consensus estimates. Global direct-to-consumer (DTC) sales rose 6% YoY, driven by continued brand elevation with double-digit growth rates in average unit retail (AUR) and full-price retail performance.

North American revenues rose 2% to $668 million. Comparable store sales rose 3%, and brick-and-mortar locations saw a 6% increase offset by a 4% decrease in digital sales. North American wholesale revenues fell 2% but were still ahead of expectations as the company managed to sell in alignment with consumer demand.

Mixed Guidance from Petco and Ralph Lauren

Petco’s In-Line Guidance

Petco provided in-line guidance for Q2 2024, forecasting an EPS loss of 2 cents, matching consensus analyst estimates. Revenues are expected to be around $1.525 billion, slightly beating the consensus estimate of $1.52 billion. The company projects full-year 2024 net interest expense to be around $145 million and capital expenditures (CAPEX) to be $140 million. Additionally, Petco announced a 10% increase in its quarterly dividend.

Ralph Lauren’s Lowered Guidance

Ralph Lauren offered a less optimistic outlook, guiding fiscal Q1 2025 revenues below prior-year estimates, against the consensus estimate of 3.3% growth or $1.55 billion. Despite this, the company expects revenue growth on a constant currency (CC) basis, though the outlook includes a 50 basis points negative impact from the timing of an earlier Easter, which benefited fiscal Q4 2024.

For the fiscal full year 2025, Ralph Lauren anticipates revenue growth of 2% to 3% on a CC basis compared to the previous year.

Ralph Lauren CEO’s Insights

Before you consider Petco Health and Wellness, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Petco Health and Wellness wasn’t on the list.

While Petco Health and Wellness currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.